Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts

References

• PiepoliMFHoesAWAgewallS2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)Eur Heart J201637292315238127222591
   PubMed Web of Science ®Google Scholar
• National Vascular Disease Prevention AllianceGuidelines for the Management of Absolute Cardiovascular Disease RiskCanberra AustraliaNational Stroke Foundation2012 Available from: https://www.heartfoundation.org.au/images/uploads/publications/Absolute-CVD-Risk-Full-Guidelines.pdfAccessed January 28, 2018
   Google Scholar
• JamesPAOparilSCarterBL2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (jnc 8)JAMA2014311550752024352797
   PubMed Web of Science ®Google Scholar
• National Heart Foundation of AustraliaGuideline for the diagnosis and management of hypertension in adultsMelbourneNational Heart Foundation of Australia2016 Available from: http://heartfoundation.org.au/for-professionals/clinical-information/hypertensionAccessed January 28, 2018
   Google Scholar
• NPS MedicinewiseKey points on fixed dose combination medicines: NPS Medicinewise2013 [updated 20 Dec 2013]. Available from: http://www.nps.org.au/topics/combination-medicines/for-health-professionals/key-pointsAccessed January 28, 2018
   Google Scholar
• Commonwealth Department of HealthPharmaceutical Benefits Schedule pbs.gov.au2016 Available from: http://www.pbs.gov.au/medicine/item/9373HAccessed January 28, 2018
   Google Scholar
• Commonwealth Department of Health and AgeingNational Medicines PolicyCanberra ACTCommonwealth Government2000 Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/national-medicines-policyAccessed January 28, 2018
   Google Scholar
• GadzhanovaSIlomäkiJRougheadEEAntihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective studyInt J Clin Pharm201335461362023677815
   PubMed Web of Science ®Google Scholar
• GadzhanovaSRougheadEEBartlettLELong-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in AustraliaEur J Clin Pharmacol201672676577126961086
   PubMed Web of Science ®Google Scholar
• SchafferALPearsonS-ABuckleyNAHow does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006–2014)Br J Clin Pharmacol20168241134114527302475
   PubMed Web of Science ®Google Scholar
• LeungAANerenbergKDaskalopoulouSSHypertension Canada’s 2016 Canadian Hypertension Education Program Guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertensionCan J Cardiol201632556958827118291
   PubMed Web of Science ®Google Scholar
• DüsingRThe case for single pill combinationsCurr Med Res Opin201430122423242425222763
   PubMed Web of Science ®Google Scholar
• BangaloreSLeyLImproving treatment adherence to antihypertensive therapy: the role of single-pill combinationsExpert Opin Pharmacother201213334535522220825
   PubMed Web of Science ®Google Scholar
• BaserOAndrewsLMWangLXieLComparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapyJ Med Econ201114557658321728914
   PubMedGoogle Scholar
• ZengFPatelBVAndrewsLFrech-TamasFRudolphAEAdherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimensCurr Med Res Opin201026122877288721067459
   PubMed Web of Science ®Google Scholar
• PatelBVScott LeslieRThiebaudPAdherence with single-pill amlodipine/atorvastatin vs a two-pill regimenVasc Health Risk Manag20084367368118827917
   PubMedGoogle Scholar
• PanjabiSLaceyMBancroftTCaoFTreatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patientsJ Am Soc Hypertens201371466023321404
   PubMed Web of Science ®Google Scholar
• SimonsLAOrtizMCalcinoGPersistence with a single pill versus two pills of amlodipine and atorvastatin: the Australian experience, 2006–2010Med J Aust2011195313413721806531
   PubMed Web of Science ®Google Scholar
• XieLFrech-TamasFMarrettEBaserOA medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapyCurr Med Res Opin201430122415242225222764
   PubMed Web of Science ®Google Scholar
• MachnickiGOngSHChenWWeiZJKahlerKHComparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costsCurr Med Res Opin201531122287229626397178
   PubMed Web of Science ®Google Scholar
• HolmesEAFHughesDAMorrisonVLPredicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical researchValue Health201417886387625498782
   PubMed Web of Science ®Google Scholar
• ProchaskaJOTranstheoretical model of behavior changeGellmanMDTurnerJREncyclopedia of Behavioral MedicineNew York, NYSpringer201319972000
   Google Scholar
• MunroSLewinSSwartTVolminkJA review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS?BMC Public Health2007710417561997
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to Long Term Therapies: Evidence for ActionGeneva, SwitzerlandWorld Health Organization2003 Contract No.: ISBN 92 4 154599 2
   Google Scholar
• BrawleyLRCulos-ReedSNStudying adherence to therapeutic regimensControl Clin Trials2000215 SupplS156S163
   Google Scholar
• ReachGRole of habit in adherence to medical treatmentDiabet Med200522441542015787666
   PubMed Web of Science ®Google Scholar
• Alison PhillipsLLeventhalHLeventhalEAAssessing theoretical predictors of long-term medication adherence: patients’ treatment-related beliefs, experiential feedback and habit developmentPsychol Health201328101135115123627524
   PubMed Web of Science ®Google Scholar
• PBS Information Management Section PPBPBS Expenditure and Prescriptions twelve months to 30 June 2015Health DoCanberra ACT pbs.gov.au2015 Available from: http://www.pbs.gov.au/info/statistics/pbs-expenditure-prescriptions-30-june-2015Accessed April 10, 2018
   Google Scholar
• PaigeEKemp-CaseyAKordaRBanksEUsing Australian Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: challenges and approachesPublic Health Res Pract2015254e254154626536508
   PubMedGoogle Scholar
• Van GoolKParkinsonBKennyPMedicare Australia data for research: an introductionCentre for Health Economic Research and Evaluation UoTS2011 updated 2015 Available from: http://www.crest.uts.edu.au/pdfs/Factsheet-Medicare-Australia-UpdatedNov2015.pdfAccessed January 28, 2018
   Google Scholar
• World Health OrganizationATC Structure and PrinciplesOslo, NorwayNorwegian Institute of Public Health2009 Available from: https://www.whocc.no/atc/structureAccessed April 10, 2018
   Google Scholar
• RaebelMAPSchmittdielJPKarterAJPKoniecznyJLPSteinerJFStandardizing terminology and definitions of medication adherence and persistence in research employing electronic databasesMed Care2013518 Suppl 3S11S2123774515
   PubMed Web of Science ®Google Scholar
• VitryAWongSARougheadEERamsayEBarrattJValidity of medication based co-morbidity indices in the Australian elderly populationAust N Z J Public Health2009332128130
   Web of Science ®Google Scholar
• Commonwealth Department of Healthezetimibe + simvastatin item 9484E pbs.gov.au Department of Health2016 [updated October 2016]. Available from: https://www.pbs.gov.au/medicine/item/9484EAccessed January 28, 2018
   Google Scholar
• BaumSJSijbrandsEJGMataPWattsGFThe doctor’s dilemma: challenges in the diagnosis and care of homozygous familial hypercholesterolemiaJ Clin Lipidol20148654254925499935
   PubMed Web of Science ®Google Scholar
• Commonwealth Department of Healthamlodipine + atorvastatin item 9055N pbs.gov.au Department of Health2016 Available from: http://www.pbs.gov.au/medicine/item/9055NAccessed January 28, 2018
   Google Scholar
• QvarnströmMKahanTKeilerHPersistence to antihypertensive drug treatment in Swedish primary healthcareEur J Clin Pharmacol201369111955196423857249
   PubMed Web of Science ®Google Scholar
• PoluzziEStrahinjaPVaccheriAAdherence to chronic cardiovascular therapies: persistence over the years and dose coverageBr J Clin Pharmacol200763334635517096681
   PubMed Web of Science ®Google Scholar
• KnottRJPetrieDJHeeleyELChalmersJPClarkePMThe effects of reduced copayments on discontinuation and adherence failure to statin medication in AustraliaHealth Policy2015119562062725724823
   PubMed Web of Science ®Google Scholar
• KronishIMYeSAdherence to Cardiovascular medications: lessons learned and future directionsProgr Cardiovasc Dis2013556590600
   PubMed Web of Science ®Google Scholar
• BerglundELytsyPWesterlingRAdherence to and beliefs in lipid-lowering medical treatments: a structural equation modeling approach including the necessity-concern frameworkPatient Educat Couns2013911105112
   PubMed Web of Science ®Google Scholar
• LamWYFrescoPMedication adherence measures: an overviewBioMed Res Int2015201521704726539470
   PubMed Web of Science ®Google Scholar